Hyperfractionated radiotherapy and simultaneous cisplatin for stage-III and-IV carcinomas of the head and neck
- 1 August 1998
- journal article
- other
- Published by Springer Science and Business Media LLC in Strahlentherapie und Onkologie
- Vol. 174 (8), 397-402
- https://doi.org/10.1007/bf03038560
Abstract
To assess the survival rate, the probability of local control, the patterns of relapse and late sequelae including self-reported quality of life in patients treated with hyperfractionated radiotherapy (RT) and simultaneous CDDP chemotherapy for stage-III to stage-IV carcinomas of the head and neck.Keywords
This publication has 15 references indexed in Scilit:
- Five-Year Update of a Randomized Trial of Alternating Radiotherapy and Chemotherapy Compared With Radiotherapy Alone in Treatment of Unresectable Squamous Cell Carcinoma of the Head and NeckJNCI Journal of the National Cancer Institute, 1996
- Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional studyOral Oncology, 1995
- Development of a European Organization for Research and Treatment of Cancer (Eortc) Questionnaire Module to be Used in Quality of Life Assessments in Head and Neck Cancer PatientsActa Oncologica, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapyRadiotherapy and Oncology, 1992
- Treatment of Advanced Squamous-Cell Carcinoma of the Head and Neck with Alternating Chemotherapy and RadiotherapyNew England Journal of Medicine, 1992
- Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 1990
- Adjuvant chemotherapy in head and neck cancerBritish Journal of Cancer, 1990